European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

13 EU fundings (€0.00): What makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptation … BdlYear 2019 EU Research and Innovation programme "Horizon"

Text

Institut Curie, Paris, France

01/01/2019 EU funding: European Joint Programme on Rare Diseases
01/01/2019 EU funding (€1,381,550): individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology
04/04/2019 EU funding (€1,499,823): Vessel co-option and radioresistance in glioblastoma
29/01/2019 EU funding (€150,000): incPRINT as a platform for RNA-targeted drug discovery
03/05/2019 EU funding (€184,708): Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy
01/03/2019 EU funding (€266,250): Revolutionizing Healthcare by Tracking and Understanding Human Cells during Disease
01/06/2019 EU funding (€274,802): AGE-RELATED CHANGES IN HEMATOPOIESIS
16/09/2019 EU funding (€274,802): What makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptation
21/05/2019 EU funding (€3,173,040): Institut Curie EuReCa PhD Programme
01/03/2019 EU funding (€410,000): Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts
01/01/2019 EU funding (€534,250): EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine.
13/08/2019 EU funding (€549,604): International NETwork for training and innovations in THErapeutic RADiation
06/09/2019 EU funding (€549,604): Training European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back again.
tax haven banner

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Institut Curie, Paris, France.

Creative Commons License The visualizations for "Institut Curie - 13 EU fundings (€0.00): What makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptation …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close